Last updated: July 16, 2023
Sponsor: Pepperdine University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
BR-LOW
BR-MOD
PL
Clinical Study ID
NCT05957835
RT12
Ages 18-45 Male Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Recreationally active males who performed resistance exercise at least twice weeklyfor the last two years
Exclusion
Exclusion Criteria:
- individuals with contraindications to exercise, cardiometabolic disease, currentlyconsuming dietary supplements containing caffeine, sodium bicarbonate, creatine,beta-alanine, and/or NO precursor supplements (i.e., NO3-, arginine, citrulline,antioxidants), females, and smokers
Study Design
Total Participants: 18
Treatment Group(s): 4
Primary Treatment: BR-LOW
Phase:
Study Start date:
May 23, 2023
Estimated Completion Date:
June 30, 2024
Study Description
Connect with a study center
Pepperdine University
Malibu, California 90263
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.